Use of B-Cell–Depleting Therapy in Women of Childbearing Potential

Por um escritor misterioso
Last updated 02 julho 2024
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Impact of B-Cell–Targeted Therapies on Cardiovascular Disease
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Frontiers Immunosuppressive Mechanisms of Regulatory B Cells
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Biomedicines, Free Full-Text
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Stem cell-based therapy for human diseases
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Mechanism of Action MONJUVI® (tafasitamab-cxix)
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
IJMS, Free Full-Text
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Ocrelizumab during pregnancy and lactation: Rationale and design
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Relapsing-Remitting Multiple Sclerosis Treatment: B Cell-Depletion
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential
Cells, Free Full-Text

© 2014-2024 miaad.org. All rights reserved.